Where is Eli Lilly in this year’s Pharm Exec 50?

May 21st, 2012
Pharmaceutical Executive Magazine just released it’s 2012 Pharm Exec 50, where companies are ranked according to global human prescription drug sales for fiscal year 2011.  Lilly came in at number 10 behind Johnson & Johnson and Abbott.  Lilly slid one position from 2011 when it ranked 9th.  See the article here.

The Indy 500 and Investments

May 14th, 2012
The stock market has experienced a fairly steady rise upward this year with the S&P 500 returning 11.88% through the end of April.  Real estate as an asset class has performed even better, with the DJ US Select REIT TR index posting a 14.09% gain so far.  Growth has outperformed value thus far in large … more »

Harnessing Risk in Any Market

Feb 21st, 2012
If you’re an outdoor enthusiast, at some point or another you’ve probably contemplated what you might do should you encounter a bear or other wild animal. Wildlife experts typically recommend these tips: Stay calm and don’t run. Investors might also do well to heed that advice when traversing the stock market. Plan ahead — Rather … more »

Discipline and Patience

Feb 20th, 2012
As you are no doubt aware, stocks have experienced much volatility over the last few years.  This is a good time to remember that the market doesn’t deliver returns in a straight line.  Market ups and downs are normal, and it takes a lot of them to balance out to the average.    Investing based on … more »

Eli Lilly newsletter

Helpful financial information and tips delivered straight to your inbox.
  • This field is for validation purposes and should be left unchanged.